The MOD of TGF-β1 in the III–IV stage group of ovarian cancer was 0.440±0.064 and its intensity was stronger than in the I–II stage group (0.426±0.055), but the difference did not reach statistical significance (P>0.05). The gene discussed is TGFB1; the disease is ovarian carcinoma.